Literature DB >> 11163213

Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.

A Salmeen1, J N Andersen, M P Myers, N K Tonks, D Barford.   

Abstract

The protein tyrosine phosphatase PTP1B is responsible for negatively regulating insulin signaling by dephosphorylating the phosphotyrosine residues of the insulin receptor kinase (IRK) activation segment. Here, by integrating crystallographic, kinetic, and PTP1B peptide binding studies, we define the molecular specificity of this reaction. Extensive interactions are formed between PTP1B and the IRK sequence encompassing the tandem pTyr residues at 1162 and 1163 such that pTyr-1162 is selected at the catalytic site and pTyr-1163 is located within an adjacent pTyr recognition site. This selectivity is attributed to the 70-fold greater affinity for tandem pTyr-containing peptides relative to mono-pTyr peptides and predicts a hierarchical dephosphorylation process. Many elements of the PTP1B-IRK interaction are unique to PTP1B, indicating that it may be feasible to generate specific, small molecule inhibitors of this interaction to treat diabetes and obesity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163213     DOI: 10.1016/s1097-2765(00)00137-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  131 in total

1.  Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling.

Authors:  J N Andersen; A Elson; R Lammers; J Rømer; J T Clausen; K B Møller; N P Møller
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.

Authors:  G Scapin; S Patel; V Patel; B Kennedy; E Asante-Appiah
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 3.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response.

Authors:  Navasona Krishnan; Cexiong Fu; Darryl J Pappin; Nicholas K Tonks
Journal:  Sci Signal       Date:  2011-12-13       Impact factor: 8.192

5.  Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop.

Authors:  David A Critton; Lutz Tautz; Rebecca Page
Journal:  J Mol Biol       Date:  2010-11-19       Impact factor: 5.469

6.  Structure-based prediction of free energy changes of binding of PTP1B inhibitors.

Authors:  Jing Wang; Shek Ling Chan; Kal Ramnarayan
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

7.  The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase.

Authors:  Christopher H Gray; Valerie M Good; Nicholas K Tonks; David Barford
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

8.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

9.  The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities.

Authors:  Xavier Espanel; Martine Huguenin-Reggiani; Rob Hooft van Huijsduijnen
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

10.  S-nitrosylation of endogenous protein tyrosine phosphatases in endothelial insulin signaling.

Authors:  Ming-Fo Hsu; Kuan-Ting Pan; Fan-Yu Chang; Kay-Hooi Khoo; Henning Urlaub; Ching-Feng Cheng; Geen-Dong Chang; Fawaz G Haj; Tzu-Ching Meng
Journal:  Free Radic Biol Med       Date:  2016-08-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.